Oncternal Therapeutics, Inc. (ONCT)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	21	32	56	112	109	61
Market Cap Growth	-42.21%	-43.88%	-49.79%	2.47%	80.16%	223.98%
Enterprise Value	-6	-2	-7	22	-7	41
PE Ratio	-	-0.80	-1.27	-3.58	-6.36	-1.78
PS Ratio	18.00	40.28	37.81	26.00	32.44	25.06
PB Ratio	0.90	1.05	0.92	1.27	0.97	4.25
P/FCF Ratio	-0.93	-0.98	-1.53	-4.22	-6.26	-3.63
P/OCF Ratio	-0.93	-0.98	-1.53	-4.22	-6.26	-3.63
EV/Sales Ratio	-0.10	-2.95	-4.90	4.98	-2.13	16.87
EV/EBITDA Ratio	0.00	0.06	0.17	-0.69	0.42	-1.20
EV/EBIT Ratio	0.00	0.06	0.17	-0.69	0.42	-1.20
EV/FCF Ratio	0.00	0.07	0.20	-0.81	0.41	-2.44
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.00	0.01
Debt / EBITDA Ratio	-0.01	-0.01	0.00	0.00	0.00	-0.01
Debt / FCF Ratio	-0.01	-0.01	0.00	0.00	0.00	-0.01
Quick Ratio	4.42	6.59	8.30	16.61	19.93	2.73
Current Ratio	4.66	6.94	8.76	16.99	20.14	2.83
Asset Turnover	0.03	0.02	0.02	0.04	0.08	0.10
Return on Equity (ROE)	-107.70%	-95.90%	-62.30%	-31.90%	-46.40%	-179.40%
Return on Assets (ROA)	-91.00%	-83.60%	-56.70%	-30.10%	-38.50%	-136.30%
Return on Capital (ROIC)	-165.27%	-137.35%	-73.62%	-35.56%	-15.53%	-228.30%
Earnings Yield	-175.60%	-124.86%	-78.40%	-27.93%	-15.73%	-56.25%
FCF Yield	-138.21%	-101.72%	-65.15%	-23.70%	-15.98%	-27.55%
Buyback Yield / Dilution	-1.13%	-11.79%	-6.65%	-142.90%	-96.58%	-187.64%
Total Shareholder Return	-1.13%	-11.79%	-6.65%	-142.90%	-96.58%	-187.64%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).